Interleukin-6: A novel biomarker for monoclonal antibody and chemotherapy-associated hypersensitivity confirms a cytokine release syndrome phenotype-endotype association.

Authors :: Jakubovic BD
Sanchez-Sanchez S
Hamadi S
Lynch DM
Castells M
Source :: Allergy [Allergy] 2021 May; Vol. 76 (5), pp. 1571-1573. Date of Electronic Publication: 2020 Nov 19.
Publication Year :: 2021

Subjects :: Biomarkers
Cytokine Release Syndrome
Desensitization, Immunologic
Humans
Phenotype
Antibodies, Monoclonal adverse effects
Drug Hypersensitivity diagnosis
Interleukin-6 blood

Full Text Access

Tools